Clinical Trial Update: Salvage Ovarian FANG™ Vaccine + Bevacizumab [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Salvage OVARIAN FANG vaccine in combination with bevacizumab for Stage III/IV ovarian cancer has completed with results posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• Salvage OVARIAN FANG vaccine (FANG)

Snippet

Sponsor: Gradalis, Inc. | Conditions: Stage III Ovarian Cancer, Stage IV Ovarian Cancer | Phase 2 | Status: COMPLETED | Results posted: 2018-05-01